Jaime
Masjuan Vallejo
Profesor/a Asociado/a en CC. de la Salud
Instituto de Investigación Sanitaria Hospital 12 de Octubre
Madrid, EspañaPublications in collaboration with researchers from Instituto de Investigación Sanitaria Hospital 12 de Octubre (4)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban
Journal of comparative effectiveness research, Vol. 12, Núm. 3, pp. e220049
2022
-
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry
European heart journal. Cardiovascular pharmacotherapy, Vol. 9, Núm. 1, pp. 38-46
-
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries
Journal of comparative effectiveness research, Vol. 11, Núm. 16, pp. 1173-1184